Arcellx, Inc.
- ACLX
- NASDAQ
- Biotechnology
- Cell Therapy (CAR-T)
- Oncology Biotech
$115.07
Today +0.02%Quote May 15, 2026, 08:00 PM UTC
+0.26%over the last month
Max drawdown −0.1%From 1-month high −0.0%3 months +68.9%
Our viewPro
The call stays with Pro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Market value
$6.73B
Quote May 15
Next earnings
—
Data unavailable
Analyst target
$103.93
−9.7% from here
Floor
$114.72
0.3% below price
Where the price sits
18 analysts
Analyst range, low to high
$38.00$120.00
- Price $115.07
- Resistance $115.14
- Consensus $103.93
The price is just above its floor and right under resistance. Analysts' average target sits about 10% lower. Their range is wide.
The call stays with Pro
7 locked chapters- What to do with this namePro
- Why nowPro
- Why this stockPro
- Section write-upsPro
- Story timelinePro
- News briefPro
- Ask about ACLXPro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Log in — 14 days freeWhere the money comes from
No revenue split by segment on file.
Industry
Biotechnology
Employees
163